Bristol Myers Squibb (BMY) Dividends payables (QoQ) (2009 - 2015)

Bristol Myers Squibb (BMY) Dividends payables (QoQ) (2009 - 2015) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 2.99%
Sep 30, 2015 0.32%
Jun 30, 2015 0.16%
Mar 31, 2015 -1.86%
Dec 31, 2014 3.53%
Sep 30, 2014 0.32%
Jun 30, 2014 0.32%
Mar 31, 2014 -2.37%
Dec 31, 2013 3.76%
Sep 30, 2013 0.83%
Jun 30, 2013 0.83%
Mar 31, 2013 -0.83%
Dec 31, 2012 1.68%
Sep 30, 2012 -0.33%
Jun 30, 2012 0.84%
Mar 31, 2012 -0.67%
Dec 31, 2011 3.29%
Sep 30, 2011 -0.17%
Jun 30, 2011 0.17%
Mar 31, 2011 0.52%